EnterpriseTuesday, July 7, 2026
Certara teams with NVIDIA to put BioNeMo agents into drug development
Certara is embedding NVIDIAs BioNeMo Agent Toolkit into its drug development platform, letting agents reason over validated models to optimize dosing, simulate trials and prepare regulatory ready evidence while keeping scientists in the loop.
Read the original source$ part of the KMM daily AI analysis · published automatically